Metlife (NYSE:MET) is set to announce its earnings results after the market closes on Tuesday, January 30th.
Metlife (NYSE:MET) last announced its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the consensus estimate of $0.90 by $0.19. The company had revenue of $16.10 billion during the quarter, compared to the consensus estimate of $15.47 billion. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The company’s quarterly revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.28 EPS. On average, analysts expect Metlife to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of Metlife (NYSE:MET) opened at $53.85 on Tuesday. The company has a market cap of $56,670.00, a P/E ratio of 117.07, a PEG ratio of 1.19 and a beta of 1.49. Metlife has a 52-week low of $44.26 and a 52-week high of $55.91. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31.
In other Metlife news, insider Christopher G. Townsend sold 55,712 shares of the firm’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares in the company, valued at approximately $1,367,076.49. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of the firm’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the transaction, the insider now owns 49,660 shares in the company, valued at $2,711,436. The disclosure for this sale can be found here. Company insiders own 0.32% of the company’s stock.
Several analysts have recently commented on MET shares. ValuEngine raised shares of Metlife from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 26th. Wells Fargo & Co reaffirmed an “outperform” rating and set a $60.00 price objective (up previously from $55.00) on shares of Metlife in a research report on Tuesday, October 3rd. They noted that the move was a valuation call. Morgan Stanley raised their price objective on shares of Metlife from $54.00 to $55.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 5th. TheStreet raised shares of Metlife from a “c+” rating to a “b” rating in a research report on Wednesday, October 4th. Finally, Zacks Investment Research raised shares of Metlife from a “strong sell” rating to a “hold” rating in a research report on Monday, October 9th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. Metlife has an average rating of “Hold” and an average price target of $57.77.
ILLEGAL ACTIVITY NOTICE: “Metlife (MET) Set to Announce Earnings on Tuesday” was published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/01/23/metlife-met-set-to-announce-earnings-on-tuesday.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.